CN Patent

CN120827525A — 非晶型激酶抑制剂制剂及其使用方法

Assigned to Deciphera Pharmaceuticals LLC · Expires 2025-10-24 · 1y expired

What this patent protects

本文提供一种式(I)表示的非晶型化合物及其组合物，其用于治疗与c‑KIT和PDGFRα激酶活性及其致癌形式相关的病症。

USPTO Abstract

本文提供一种式(I)表示的非晶型化合物及其组合物，其用于治疗与c‑KIT和PDGFRα激酶活性及其致癌形式相关的病症。

Drugs covered by this patent

Patent Metadata

Patent number: CN120827525A
Jurisdiction: CN
Classification: —
Expires: 2025-10-24
Drug substance claim: No
Drug product claim: No
Assignee: Deciphera Pharmaceuticals LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.